Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on July 14, 2026

4 hours ago

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

Indeterminate GlobeNewswire

4 hours ago

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

Indeterminate GlobeNewswire

4 hours ago

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Indeterminate GlobeNewswire

4 hours ago

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding 

Indeterminate GlobeNewswire

4 hours ago

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Indeterminate GlobeNewswire

4 hours ago

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

Indeterminate GlobeNewswire

4 hours ago

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire

4 hours ago

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Indeterminate GlobeNewswire

4 hours ago

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

4 hours ago

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Indeterminate GlobeNewswire

5 hours ago

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

Indeterminate GlobeNewswire

5 hours ago

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Indeterminate GlobeNewswire

5 hours ago

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

5 hours ago

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Indeterminate GlobeNewswire

5 hours ago

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Indeterminate GlobeNewswire

5 hours ago

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Indeterminate GlobeNewswire

5 hours ago

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Indeterminate GlobeNewswire

5 hours ago

Foundation for Sarcoidosis Research Announces 13 Inaugural Sites for Groundbreaking FSR Clinical Data Registry

Indeterminate GlobeNewswire

6 hours ago

Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

Indeterminate GlobeNewswire

6 hours ago

NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy

Indeterminate GlobeNewswire